FDA Commissioner Marty Makary talks the ‘AI revolution’ at the agency
Makary shared his thoughts on AI’s future potential in an interview with Healthcare Brew.
Makary shared his thoughts on AI’s future potential in an interview with Healthcare Brew.
Is direct to employer the new direct to consumer?
Johnson & Johnson, Amgen, and Fujifilm Biotechnologies have all recently invested in the RTP.
“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.
At the center is a proposal to shift how drugs are paid for.
The partnership will allow the drug company new access to key data.
This year’s game was punctuated by more pharma commercials, though some experts wonder if regulations might squash that momentum.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.